NCT01312389 2021-11-15A Clinical Trial of Autologous Oxidized Tumor Cell Lysate Vaccine For Recurrent Ovarian, Fallopian Tube or Primary Peritoneal CancerAbramson Cancer Center at Penn MedicinePhase 1/2 Terminated3 enrolled 4 charts